No abstract available
Keywords:
clinical research/practice; immunobiology; infection and infectious agents-viral; infectious disease; organ transplantation in general; vaccine.
PubMed Disclaimer
References
-
-
Blumberg EA, Manuel O, Sester M, Ison MG. The future of SARS-CoV-2 vaccines in transplant recipients: to be determined [published online ahead of print 2021]. Am J Transplant. 2021. 10.1111/ajt.16598. Epub ahead of print.
-
DOI
-
PMC
-
PubMed
-
-
Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786. doi: 10.1001/jama.2021.4385.
-
DOI
-
PMC
-
PubMed
-
-
Marinaki S, Adamopoulos S, Degiannis D, et al. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients [published online ahead of print 2021]. Am J Transplant. 2021. 10.1111/ajt.16607. Epub ahead of print.
-
DOI
-
PMC
-
PubMed
-
-
Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus [published online ahead of print 2021]. Am J Transplant. 2021. 10.1111/ajt.16615. Epub ahead of print.
-
DOI
-
PMC
-
PubMed
-
-
Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant. 2021;21(3):938–949. doi: 10.1111/ajt.16295.
-
DOI
-
PubMed
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous